InvestorsHub Logo
Followers 829
Posts 119628
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 3090

Tuesday, 05/04/2021 9:23:06 AM

Tuesday, May 04, 2021 9:23:06 AM

Post# of 6132
PFE—>$3.5B_COVID-19_vaccine_sales_in 1Q21—raises_2021_non-GAAP_EPS_guidance_to_$3.55-3.65 (from prior range of $3.10-3.20):

1Q21 PR:
https://s21.q4cdn.com/317678438/files/doc_financials/2021/q1/Q1-2021-PFE-Earnings-Release.pdf

CC slides:
https://s21.q4cdn.com/317678438/files/doc_financials/2021/q1/Q1-2021-Earnings-Charts-FINAL.pdf

PFE now expects full-year 2021 COVID-19 revenue of $26B—up from the $15B guidance three months ago.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PFE News